ArticleArthritis research & therapy2026
Cytokine profiling of molecular endotypes of knee osteoarthritis: insights from the IMI-APPROACH cohort.
Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Circulating sTLR4 and sTREM-1 in Knee Osteoarthritis: Associations with Study-Specific MRI-Defined Categories and Disease Burden.Journal of clinical medicine · 2026Article
- Recent advances in understanding molecular and clinical heterogeneity in osteoarthritis: one disease or several?Osteoarthritis imaging · 2026Article
- Immuno-based profiling of knee osteoarthritis patients identifies baseline characteristics associated with positive response to autologous platelet-rich plasma injection at one-year follow-up.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMolecular endotypes that decipher the heterogeneity of osteoarthritis (OA) have been described. This exploratory study aimed to further the molecular understanding of three previously identified biomarker-based endotypes of knee OA through cytokine profiling.
methodsFifteen pro- and anti-inflammatory cytokines were measured in serum at the six-, 12-, and 24-month follow-up visits of 277 knee OA participants from IMI-APPROACH using Luminex multiplexed immunoassays. Longitudinal differences in cytokine levels between previously defined endotype subgroups; (i) structural damage to bone and cartilage, (ii) low tissue turnover, and (iii) connective tissue inflammation were estimated with linear mixed-effects models, adjusting for patient-specific random effects, age, sex, and BMI. Within-patient stability of the cytokines over 18 months was compared to 19 tissue turnover biomarkers of which defined the endotypes.
resultsCompared to tissue-turnover biomarkers measured in IMI-APPROACH, the panel of 15 cytokines demonstrated increased fluctuations over time with lower within-patient stability and less discriminatory abilities between the endotype. Only the anti-inflammatory cytokine interleukin-1 receptor antagonist (IL-1ra) was consistently and differentially elevated in the inflammatory endotype subgroup (n = 92). At the 12-month visit, a mean change of IL-1ra of 36% (95% CI: 19%, 54%; p-value < 0.001) was found for the inflammatory endotype relative to the structural damage endotype, and 40% (95% CI: 22%, 59%; p-value < 0.001) at month 24. At the 24-month visit, a mean change of IL-1ra of 21% (95% CI: 10%, 31%; p-value = 0.047) was found for the inflammatory endotype relative to the low tissue turnover endotype. Participants with the highest quartile expression of IL-1ra within the inflammatory endotype (n = 23) exhibited higher BMI (p = 0.035, Mann-Whitney U test) and worsened Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function (p = 0.035, Mann-Whitney U test) compared to the lowest quartile of IL-1ra expression.
conclusionsThis study found that the majority of the cytokines exhibited considerable fluctuations over time with no endotype-specific cytokine profiles. This study indicates that while the included cytokines are important for the understanding of OA pathology, they may not be stable reflections of the endotypic profiles of KOA over time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.